ºÚÁÏÍø

Insights in Gynecologic Oncology
ºÚÁÏÍø

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ ºÚÁÏÍø Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

ºÚÁÏÍø Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Editorial Board
Editor Image

Editor-In-Chief
Samir A. Farghaly
Physician / Scientist
Obstetrics and Gynecology
Cornell University
New York
USA

Editor Image

Rouba Ali - Fehmi
Department of Pathology and OB/GYN
Wayne State University
Michigan
USA

Editor Image

Georgios Androutsopoulos
Assistant Professor
Obstetrics & Gynecology
University of Patras
Greece

Editor Image

Anjum Memon
Senior Lecturer and Honorary Consultant in Public Health Medicine
University of Brighton
U.K.

Submit Manuscript

Journal Impact Factor 0.11*
Submit manuscript at or send as an e-mail attachment to the Editorial Office at manuscript@omicsonline.org

If you are interested in publishing with us or have any questions, please feel free to contact us directly on WhatsApp .

About the Journal

Gynecological Oncology

Gynecological Oncology is a specialized field of medication that emphasis on cancers of the , including ovarian cancer, uterine cancer, vaginal cancer, cervical cancer, and vulvar cancer. As consultants, they have all-encompassing preparation in the identification and treatment of these cancers.

Related Journals of Gynecological Oncology
Andrology & Gynecology: Current Research, Critical Care Obstetrics & Gynecology, Gynecology & Obstetrics, Archives of Surgical Oncology, Integrative Oncology, Oncology & Cancer Case Reports, Oncology Translational Research, Women's Health, Issues & Care, Gynecologic Oncology, Society of Gynecologic Oncology, Journal of Gynecologic Oncology, International Journal of Gynecologic Cancer, Journal of Clinical Oncology Gynecologic Cancers Portal

Vaginal Cancer

Vaginal Cancer is an uncommon sort of cancer that starts in the vagina. Around 260 new cases are analyzed in the UK every year. that starts in the vagina is called Pri-vaginal cancer. Growth that starts in another piece of the body –, for example, the cervix, womb or – and spreads to the vagina is known as auxiliary .

Related Journals of Vaginal Cancer
Andrology & Gynecology: Current Research, Critical Care Obstetrics & Gynecology, Gynecology & Obstetrics, Archives of Surgical Oncology, Integrative Oncology , Oncology & Cancer Case Reports, Oncology Translational Research, Women's Health, Issues & Care, Current Treatment Options in Oncology, International Journal of Gynecological Cancer, New York Medical Journal, Journal of Lower Genital.

Uterine Cancer

Uterine cancer is the formation of a malicious tumor that starts in the lining of the cells of the Malicious means that it can blowout, or metastasize, to other parts of the body. The uterus is also called the . It is part of a woman's reproductive system.

Related Journals of Uterine Cancer
Andrology & Gynecology: Current Research, Critical Care Obstetrics & Gynecology, Gynecology & Obstetrics, Archives of Surgical Oncology, Integrative Oncology, Oncology & Cancer Case Reports, Oncology Translational Research, Women's Health, Issues & Care, International Journal of Epidemiology, International Journal of Gynecological Cancer, Annals of Oncology

Reproductive Cancer

can happen in anywhere in the female conceptive framework the vulva, , cervix, , fallopian tubes, or These tumors are called gynecologic . Gynecologic malignancies can specifically attack close-by tissues and organs or spread (metastasize) through the and lymph hubs (lymphatic framework) or circulation system to removed parts of the body.

Related Journals of Reproductive Cancer
Andrology & Gynecology: Current Research, Critical Care Obstetrics & Gynecology, Gynecology & Obstetrics, Archives of Surgical Oncology, Integrative Oncology , Oncology & Cancer Case Reports, Oncology Translational Research, Women's Health, Issues & Care, Contraception: An International Reproductive Health, British Journal of Cancer, Asian Pacific Journal of Reproduction-Elsavier, Journal of Thoracic Oncology, International Journal of Palliative Nursing

Quality of Life of Patients with Gynecologic Cancers

Importance of natural life is an idea that is without a moment's delay clear and fleeting. There are the same numbers of definitions as there are eyewitnesses. Elements adding to a quality life additionally change over the lifetime of an individual and consider different physical, scholarly, and monetary open doors and restrictions. Personal satisfaction is impacted by outside powers and natural abilities. People are colossally versatile. Disease survivorship is a procedure with both positive and negative perspectives. Albeit much is thought about survival rates and inconveniences of treatment for gynecologic malignancies, the issue of personal satisfaction has been tended to just as of late. The consequences of preparatory concentrates just demonstrate how complex the issues are and that they are so hard to evaluate.

Primary Peritoneal Cancer

(PPC) is a moderately uncommon cancer that grows most normally in ladies. is a nearby relative of epithelial ovarian cancer, which is the most well-known sort of harm that influences the ovaries. The reason for essential is unidentified. It is essential for ladies to realize that it is conceivable to have essential peritoneal malignancy cancer of the fact that their ovaries have been uprooted.

Related Journals of Primary Peritoneal Cancer
Andrology & Gynecology: Current Research, Critical Care Obstetrics & Gynecology, Gynecology & Obstetrics, Archives of Surgical Oncology, Integrative Oncology , Oncology & Cancer Case Reports, Oncology Translational Research, Women's Health, Issues & Care, International Journal of Surgical Oncology, Journal of Case Reports and Images, European Journal of Obstetrics and Gynecology, American Journal of Obstetrics and Gynecology

Ovarian Tumors

Three sorts of ovarian are:

tumors- begin from the cells on the surface of the ovaries. These are the most well-known sort of ovarian tumors.
Germ cell tumors- begin in the cells that create the eggs. They can either be favorable or malignant.
Stromal tumors- start in the cells that produce

Related Journals of Ovarian Tumors
Andrology & Gynecology: Current Research, Critical Care Obstetrics & Gynecology, Gynecology & Obstetrics, Archives of Surgical Oncology, Integrative Oncology , Oncology & Cancer Case Reports, Oncology Translational Research, Women's Health, Issues & Care, Journal of Ovarian Research, Clinical Ovarian and other Gynecologic Cancer, International Journal of Gynecological Cancer, Journal of Ovarian Research Elsavier

Ovarian Cancer Prognosis

Ovarian Cancer Prognosis, Five-year survival for is most elevated in the most youthful ladies and reductions with expanding age. Five-year net survival reaches from 87% in 16-40 year-olds to 18% in 79-98 year-olds for patients determined to have in England amid 2008-2012

Related Journals of Ovarian Cancer Prognosis
Andrology & Gynecology: Current Research, Critical Care Obstetrics & Gynecology, Gynecology & Obstetrics, Archives of Surgical Oncology, Integrative Oncology , Oncology & Cancer Case Reports, Oncology Translational Research, Women's Health, Issues & Care, Journal of Ovarian Research, Clinical Ovarian and other Gynecologic Cancer, International Journal of Gynecological Cancer, Journal of Ovarian Research Elsavier

Ovarian Cancer

This type of cancer starts with a harmful tumor of the the egg sac in a female. Ladies who have a family history of ovarian disease are at an expanded danger of creating ovarian growth. Genetic ovarian malignancy makes up a little rate of all instances of .

Related Journals of Ovarian Cancer
Andrology & Gynecology: Current Research, Critical Care Obstetrics & Gynecology, Gynecology & Obstetrics, Archives of Surgical Oncology, Integrative Oncology, Oncology & Cancer Case Reports, Oncology Translational Research, Women's Health, Issues & Care, Journal of Ovarian Research, Journal of Ovarian Research, International Journal of Gynecological Cancer, Ovarian Cancer

Omentum Cancer

Neuroblastoma is an illness in which threatening (tumor) cells form in nerve tissue of the adrenal organ, neck, midsection, or spinal rope. egularly starts in the nerve tissue of the adrenal organs. There are two adrenal organs, one on top of every in the back of the upper guts.

Related Journals of Neuroblastoma Cancer
Andrology & Gynecology: Current Research, Critical Care Obstetrics & Gynecology, Gynecology & Obstetrics, Archives of Surgical Oncology, Integrative Oncology, Oncology & Cancer Case Reports, Oncology Translational Research, Women's Health, Issues & Care, Journal of Clinical Oncology, Journal of Neuroblastoma Cancer, Journal of Clinical Pathology, International Journal of Cancer, European Journal of Cancer, Journal of Diagnostic Medical Sonography

Neuroblastoma Cancer

Neuroblastoma is an illness in which threatening (tumor) cells form in nerve tissue of the adrenal organ, neck, midsection, or spinal rope. egularly starts in the nerve tissue of the adrenal organs. There are two adrenal organs, one on top of every in the back of the upper guts.

Related Journals of Neuroblastoma Cancer
Andrology & Gynecology: Current Research, Critical Care Obstetrics & Gynecology, Gynecology & Obstetrics, Archives of Surgical Oncology, Integrative Oncology, Oncology & Cancer Case Reports, Oncology Translational Research, Women's Health, Issues & Care, Journal of Clinical Oncology, Journal of Neuroblastoma Cancer, Journal of Clinical Pathology, International Journal of Cancer, European Journal of Cancer, Journal of Diagnostic Medical Sonography

Gestational Trophoplastic Tumors

Gestational trophoblastic disease (GTD) is a gathering of uncommon tumors that include unusual development of cells inside a lady's uterus. GTD does not create from cells of the uterus like cervical tumor or endometrial (uterine coating) malignancy do. Rather, these tumors begin in the phones that would typically form into the placenta amid pregnancy. GTD starts in the layer of cells called the trophoblast that regularly encompasses a developing life. Ahead of schedule in ordinary advancement, the trophoblast's cells structure modest, finger-like projections known as villi.

Related Journals of Gestational Trophoplastic Tumors
Andrology & Gynecology: Current Research, Critical Care Obstetrics & Gynecology, Gynecology & Obstetrics, Archives of Surgical Oncology, Integrative Oncology , Oncology & Cancer Case Reports, Oncology Translational Research, Women's Health, Issues & Care, Contraception: An International Reproductive Health, British Journal of Cancer, Asian Pacific Journal of Reproduction-Elsavier, Journal of Thoracic Oncology, International Journal of Palliative Nursing

Fallopian Tube Cancer

Fallopian tube cancer, otherwise called tubal growth, grows in the that associate the ovaries and the uterus. It is extremely uncommon and represents just 1 percent to 2 percent of every single gynecologic malignancy. Around 1,500 to 2,000 instances of malignancy have been accounted for around the world.

Related Journals of Fallopian Tube Cancer
Andrology & Gynecology: Current Research, Critical Care Obstetrics & Gynecology, Gynecology & Obstetrics, Archives of Surgical Oncology, Integrative Oncology , Oncology & Cancer Case Reports, Oncology Translational Research, Women's Health, Issues & Care, British Journal of Cancer, American Journal of Roentgenology, American Journal of Obstetrics and Gynecology, Journal of Magnetic Resonance Imaging, International Journal of Gynecology & Obstetrics

Epidemiology of Gynecologic Cancers

Melanoma is often an ailment in which tissues by the body processes mature unmanageable. While cancer starts off in the woman’s reproductive: body organs, it's known as . The 5 major kinds of gynecologic cancer are usually: cervical, ovarian, uterine, and penile, in addition to vulvar. (A sixth type of gynecologic cancer may be the incredibly unusual fallopian tube cancer. Of all of the gynecologic cancer, only cervical cancer has a verification test—the —that will get this particular cancer beginning, when therapy could be most reliable. While there is absolutely no straight forward in addition to reputable approach to monitor for almost any gynecologic cancer besides cervical cancer, it's particularly imperative that you realize warning signs, in addition to learn when you can find steps to relieve your chance. There are various ways to handle gynecologic cancer. The procedure is determined by the type of cancer and in addition to how long it’s going to propagate.

Cysts and Ovaries

are liquid filled sacs that can frame in the ovaries. They are extremely normal. They are especially regular amid the childbearing years. There are a few distinct sorts of . The most widely recognized is a practical growth. It structures amid ovulation. That arrangement happens when either the egg is not discharged or the sac - follicle - in which the egg structures does not disintegrate after the egg is discharged.

Related Journals of Cysts and Ovaries
Andrology & Gynecology: Current Research, Critical Care Obstetrics & Gynecology, Gynecology & Obstetrics, Archives of Surgical Oncology, Integrative Oncology , Oncology & Cancer Case Reports, Oncology Translational Research, Women's Health, Issues & Care, Open Journal of Obstetrics and Gynecology, Cleveland Clinic Journal of Medicine, Journal of Obstetrics and Gynecology, European Journal of Obstetrics and Gynecology, Journal of Perinatology

Clinical Gynecologic Oncology

Clinical Gynecologic Oncology is a specialized clinical field of medication that emphasis on cancers of the female reproductive system, including , uterine cancer, , and vulvar cancer. As consultants, they have all-encompassing preparation in the identification and treatment of these cancers.

Related Journals of Clinical Gynecologic Oncology
Andrology & Gynecology: Current Research, Critical Care Obstetrics & Gynecology, Gynecology & Obstetrics, Archives of Surgical Oncology, Integrative Oncology, Oncology & Cancer Case Reports, Oncology Translational Research, Women's Health, Issues & Care, Indian Journal of Gynecologic Oncology, Journal of Clinical Oncology Gynecologic Cancers, Gynecologic Oncology Research and Practice, European Journal of Gynaecological Oncology, International Journal of Gynecologic Oncology

Cervical Erosin

A condition in which the squamous epithelium of the cervix is scraped as an aftereffect of bothering brought about by disease or injury, for example, labor and supplanted by columnar .

Related Journals of Cervical Erosin
Andrology & Gynecology: Current Research, Critical Care Obstetrics & Gynecology, Gynecology & Obstetrics, Archives of Surgical Oncology, Integrative Oncology , Oncology & Cancer Case Reports, Oncology Translational Research, Women's Health, Issues & Care, British Medical Journal, An International Quarterly Journal of Research in Ayurveda, Journal of Ayurveda and Holistic Medicine, European Journal of Experimental Biology

Vulva Cancer

Vulva Cancer is the of the (otherwise called vulvar growth) regularly influences the inward edges of the or the labia minora. Growth happens on the clitoris or in the bartholin organs less frequently.

Related Journals of Uterine Cancer
Andrology & Gynecology: Current Research, Critical Care Obstetrics & Gynecology, Gynecology & Obstetrics, Archives of Surgical Oncology, Integrative Oncology, Oncology & Cancer Case Reports, Oncology Translational Research, Women's Health, Issues & Care, International Federation of Gynecology and Obstetrics, International Journal of Gynecology & Obstetrics, International Journal of Reproduction, International Journal of Contraception, International Journal of Women's Health

Womb Cancer

Womb Cancer is a kind of cancer that starts in the uterus. The uterus is the empty, pear-molded in ladies where fetal development happens. Womb cancer starts in the layer of cells that frame the coating of the uterus.

Related Journals of Womb Cancer
Andrology & Gynecology: Current Research, Critical Care Obstetrics & Gynecology, Gynecology & Obstetrics, Archives of Surgical Oncology, Integrative Oncology, Oncology & Cancer Case Reports, Oncology Translational Research, Women's Health, Issues & Care, Annals of Oncology, Journal of Lower Genital, Journal of Hematology & Oncology, Journal of Cervical Cancer, International Gynecologic Cancer Society Journal, European Society of Gynaecologic Oncology Journal

Insights in Gynecologic Oncology Journal (CTGOJ) is the journal of cancers of the female in reproductive system. The journal focuses on the basic sciences and clinical aspects of Vulvar cancer, Vaginal cancer, Uterine Cervical cancer, Uterine cancer, Fallopian Tube cancer, ovarian cancer, primary peritoneal cancer, and Gestational Trophoblastic Disease ( GTD).
Insights in Gynecologic Oncology is at higher echelons that enhance the intelligence and information dissemination on topics related to Gynecologic oncology. The journal is Peer Reviewed Journal, and is supported by universally prominent Editorial Board members. The journal is an ºÚÁÏÍø Journal, and all articles are freely accessible immediately after publication.
The journal uses the Editorial Manager System for quality review process. The review process is performed by the editorial board members. At least two independent reviewers approval followed by the editor is required for the acceptance of any citable manuscript. Authors may submit manuscripts and track their progress through the system. Reviewers can download manuscripts and submit their opinions to the editor. Editors can manage the submission/review/revise/publish processes, under the supervision of the founder Editor-in-Chief. The journal accepts manuscripts for consideration of publication as editorial ( by invitation), original research, review, short review, case report, reports on national and international meetings, letter to the editors/ replies. The journal will publish, periodically, special issues related to the most advances in diagnosis and management of Gynecological cancers.

Pathological aspects and molecular pathology of all Gynecologic Cancers

Molecular Pathology of Gynecologic Cancer focuses on adding effective molecular approaches in train regarding dealing with gynecologic cancer. The quantity starts with the explication of the editors’ speculation in which cancer is often an ailment in which tissues by the body grows unmanageably, in line with the deregulation of the body procedure cell replica. This specific log concentrate on unique concerns throughout gynecologic varieties of cancer, such as: any offered style of ovarian serous carcinogenesis, molecular guns regarding ovarian epithelial cancer, a synopsis of the pathology of endometrial cancer, molecular ancestral areas of endometrial carcinoma along with cervical cancer, an organic historical past of Human Papilloma Virus (HPV) since it relates to cervical cancer, along with anatomical concerns throughout gynecologic varieties of cancer as well as a utilizing holistic way of treating woman cancer individuals.

Socio- Psychological Aspects of Gynecological Cancers

is usually an important health issue of which is the reason 23% coming from all deaths. Despite the fact that death charges through coronary disease, cerebrovascular event, along with circumstances happen to be decreasing, deaths caused by get risen nearly two fold because the 1970s. In contrast, the actual survival photograph can be far more optimistic for ladies having gynecologic malignancies, which often are the cause of 11% coming from all fresh cancers instances throughout girls. Since the 1970s, death charges with regard to gynecologic malignancies get significantly dropped: the reduction involving 21% with regard to endometrial cancers, 55% with regard to cervical, and 8% with regard to . With the somewhere around 70, 000 fresh instances every year, far more girls reside and actually handling stressors associated with the actual cancers that could become long-term.

Biomarkers and Molecular Diagnosis of all Gynaecologic Cancers

Cervical tumor is a noteworthy gynecological malignancy which includes uncontrolled cell division and tissue intrusiveness of the female uterine cervix. With the accessibility of new advancements scientists have expanded their endeavours to create novel biomarkers for right on time analysis, and assessment and checking of helpful medications. This methodology will help in the advancement of right on time analysis and in expanding treatment adequacy with diminished repeat of procedures.

Targeted Molecular Therapy for all Gynaecologic Cancers

, one of the real reasons for death from disease in ladies, is normally analyzed at cutting edge stage. Cytoreductive surgery took after by platinum and taxane-based mix chemotherapy is right now the standard treatment for ovarian tumor. Be that as it may, most patients at last repeat and create chemo-resistance. A universal study, GOG 182-ICON 5, tried to enhance the viability of standard platinum-taxane treatment by joining more current cytotoxic specialists (gemcitabine, pegylated liposomal doxorubicin, and topotecan). Then again, the blend of these specialists utilized as a part of standard treatment has not enhanced general survival. Another procedure is expected to enhance the anticipation of patients with ovarian

Advanced Endometrial Ablation Techniques

Advanced endometrial ablation techniques represent a significant advancement in the management of abnormal uterine bleeding, particularly for women who have not responded well to medical treatments. Endometrial ablation is a minimally invasive procedure designed to remove or destroy the lining of the uterus (endometrium) to reduce or eliminate heavy menstrual bleeding. Here’s an overview of the latest advancements in this field. While advanced endometrial ablation techniques offer many benefits, they are not suitable for everyone. Women with certain conditions, such as uterine cancer, significant uterine abnormalities, or those who wish to preserve fertility, may not be candidates. Additionally, potential risks and side effects include infection, bleeding, and, in rare cases, the need for additional procedures. Overall, the development of these advanced techniques in endometrial ablation has provided effective options for managing heavy menstrual bleeding, allowing for improved patient outcomes and satisfaction.

Oncofertility

Oncofertility is an interdisciplinary field that combines oncology and reproductive medicine to address the fertility preservation and reproductive health of cancer patients . It aims to provide options for individuals whose fertility may be affected by cancer treatments or diagnoses. It represents a critical area of medicine that addresses the intersection of cancer care and reproductive health, offering hope and solutions for individuals facing the dual challenges of cancer treatment and preserving their future fertility. A multidisciplinary approach ensures that all aspects of a patient's health and future reproductive options are considered. It aims to provide options for individuals whose fertility may be affected by cancer treatments or diagnoses

Premature Ovarian Failure

Premature Ovarian Failure (POF), also known as primary ovarian insufficiency, is a condition where the ovaries stop functioning normally before the age of 40. This results in decreased estrogen production and often leads to infertility . POF can be a lifelong condition, but with appropriate management, many individuals can lead a healthy life and address symptoms effectively. It’s essential to work closely with a healthcare provider to tailor the treatment to individual needs

Major Disease Statistics
Fast Editorial Execution and Review Process (FEE-Review Process):

Insights in Gynecologic Oncology is participating in the Fast Editorial Execution and Review Process (FEE-Review Process) with an additional prepayment of $99 apart from the regular article processing fee. Fast Editorial Execution and Review Process is a special service for the article that enables it to get a faster response in the pre-review stage from the handling editor as well as a review from the reviewer. An author can get a faster response of pre-review maximum in 3 days since submission, and a review process by the reviewer maximum in 5 days, followed by revision/publication in 2 days. If the article gets notified for revision by the handling editor, then it will take another 5 days for external review by the previous reviewer or alternative reviewer.

Acceptance of manuscripts is driven entirely by handling editorial team considerations and independent peer-review, ensuring the highest standards are maintained no matter the route to regular peer-reviewed publication or a fast editorial review process. The handling editor and the article contributor are responsible for adhering to scientific standards. The article FEE-Review process of $99 will not be refunded even if the article is rejected or withdrawn for publication.

The corresponding author or institution/organization is responsible for making the manuscript FEE-Review Process payment. The additional FEE-Review Process payment covers the fast review processing and quick editorial decisions, and regular article publication covers the preparation in various formats for online publication, securing full-text inclusion in a number of permanent archives like HTML, XML, and PDF, and feeding to different indexing agencies.

h-index

Articles published in Insights in Gynecologic Oncology have been cited by esteemed scholars and scientists all around the world. Insights in Gynecologic Oncology has got h-index 2, which means every article in Insights in Gynecologic Oncology has got 2 average citations.


Recently Published Articles

 
International Conferences 2024-25
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top